Mitchell Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,024
Closed -$3.38M 127
2025
Q4
$3.38M Buy
+6,024
New +$3.42M 0.6% 52
2024
Q4
Sell
-17,405
Closed -$5.81M 114
2024
Q3
$5.81M Sell
17,405
-1,009
-5% -$383K 1.02% 35
2024
Q2
$7.58M Buy
18,414
+339
+2% +$134K 1.34% 18
2024
Q1
$7.31M Buy
18,075
+646
+4% +$227K 1.4% 18
2023
Q4
$5.34M Buy
+17,429
New +$4.7M 1.12% 30

Other funds holding MEDP

Mitchell Capital Management's MEDP Position: Q1 2026 in Review

Mitchell Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 6,024 shares — an estimated $3.38M sold.

Mitchell Capital Management first reported a position in MEDP in Q4 2023 and held it in 5 quarters. The position peaked at $7.58M in Q2 2024. 733 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Mitchell Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Mitchell Capital Management sold 6,024 Medpace shares in Q1 2026, an estimated $3.38M.
  • Mitchell Capital Management first reported a position in Medpace in Q4 2023 and held it in 5 quarters.
  • Mitchell Capital Management's Medpace position peaked at $7.58M in Q2 2024.
  • 733 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Mitchell Capital Management's 13F filing for Q1 2026, filed 11 May 2026.